# v4.9

## Related releases

## Data changes

### Gene

```
ELF4 Gene Background Updated
ELF4 Gene Summary Updated
ELK4 Gene Background Updated
ELK4 Gene Summary Updated
ELL Gene Background Updated
ELL Gene Summary Updated
ELN Gene Background Updated
ELN Gene Summary Updated
ERC1 Gene Background Updated
ERC1 Gene Summary Updated
FOXN4 Gene Background Updated
FOXN4 Gene Summary Updated
GNA13 Gene Background Updated
HIRA Gene Background Updated
HIRA Gene Summary Updated
MYOD1 Gene Background Updated
ONECUT2 Gene Background Updated
ONECUT2 Gene Summary Updated
PAX5 Gene Background Updated
POU3F2 Gene Background Updated
POU3F2 Gene Summary Updated
SF3B2 Gene Background Updated
SF3B2 Gene Summary Updated
ZBTB7A Gene Background Updated
ZBTB7A Gene Summary Updated
```

### Alteration

```
BRCA1 M1628V, Oncogenicity Updated
	 New: Likely Neutral
	 Old: Likely
BRCA1 L1786P Added
BRCA2 T1526A Added
BRCA2 G2313V Added
BRCA2 K2162N Added
BRCA2 D1476G Added
BRCA2 T2515I, Mutation Effect Description Updated
EGFR S464L, Oncogenicity Updated
	 New: Resistance
	 Old: Likely Neutral
EGFR S464L, Mutation Effect Description Updated
ELF4 Amplification Added
ELF4 Gene Type Updated
ELK4 Gene Type Updated
ELK4 Amplification Added
ELK4 SLC45A3-ELK4 Fusion Added
ELL Amplification Added
ELL Gene Type Updated
ELN Gene Type Updated
ERC1 Gene Type Updated
ERC1 Amplification Added
FOXN4 Gene Type Updated
FOXN4 Amplification Added
GATA3 Truncating Mutations Deleted
GATA3 1_307trunc [N-terminal truncating mutations] Added
GATA3 308_443trunc [C-terminal truncating mutations] Added
GATA3 1_307trunc [N-terminal truncating mutations], Mutation Effect Description Updated
GATA3 308_443trunc [C-terminal truncating mutations], Mutation Effect Description Updated
GNA13 Gene Type Updated
GNA13 I158K, Oncogenicity Updated
	 New: Likely
GNA13 I305S, Oncogenicity Updated
GNA13 L197Q, Oncogenicity Updated
GNA13 D259V, Oncogenicity Updated
GNA13 L184R, Oncogenicity Updated
	 New: Inconclusive
GNA13 N283I, Oncogenicity Updated
GNA13 K292R, Oncogenicity Updated
GNA13 Y308S, Oncogenicity Updated
GNA13 F245S, Oncogenicity Updated
GNA13 Deletion Added
GNA13 C14S Added
GNA13 C18S Added
GNA13 A102V Added
GNA13 D155G Added
GNA13 D222A Added
GNA13 D364E Added
GNA13 F272L Added
GNA13 F325S Added
GNA13 G17A Added
GNA13 G224D Added
GNA13 I271N Added
GNA13 N263D Added
GNA13 N370Y Added
GNA13 Q27H Added
GNA13 T203A Added
HIRA Gene Type Updated
HIRA Deletion Added
ING1 R102L Added
ING1 N260S Added
KLHL6 L65P Added
KLHL6 S94I Added
KLHL6 F97L Added
KMT2A KMT2A-ELL Fusion Added
MET P1153L Added
MET S290F Added
MET V1155M Added
MET ST7-MET Fusion Added
MET C526F Added
MET S1141W Added
MET Y1365F Added
MET CAV1-MET Fusion Added
MET 981_1028splice, 963_1010splice [Exon 14 splice mutations], X963_splice, X1006_splice, X1007_splice, X1008_splice, X1009_splice, X1010_splice, Mutation Effect Description Updated
MLH1 R385C Added
MLH1 R725H Added
NFE2 109_372trunc [Truncating mutations in the C-terminus], Mutation Effect Description Updated
NFE2 109_372trunc [Truncating mutations in the C-terminus] Name Changed
	 New: 109_372trunc [Truncating mutations in the C-terminus]
	 Old: Truncating Mutations
ONECUT2 Gene Type Updated
ONECUT2 Amplification Added
PAX5 PAX5-ELN Fusion Added
PAX5 PAX5-ELN Fusion, Mutation Effect Updated
	 New: Likely Loss-of-function
	 Old:
PAX5 Gene Type Updated
PAX5 Amplification, Mutation Effect Description Updated
PAX5 P34Q Added
PAX5 P80R Added
POU3F2 Gene Type Updated
POU3F2 Amplification Added
SF3B2 Gene Type Updated
SLC9A3R1 E43G Added
SLC9A3R1 K172N Added
SLC9A3R1 D301V Added
SLC9A3R1 A190D Added
XRCC1 R194W Added
XRCC1 R339Q Added
XRCC1 R280H Added
ZBTB7A Amplification Added
ZBTB7A Truncating Mutations Added
ZBTB7A A175fs Added
ZBTB7A R402C Added
ZBTB7A P14S Added
ZBTB7A S22R Added
ZBTB7A R49H Added
ZBTB7A K60R Added
ZBTB7A D78E Added
ZBTB7A R112C Added
ZBTB7A P184S Added
ZBTB7A Q322L Added
ZBTB7A S326L Added
ZBTB7A S357R Added
ZBTB7A R377L Added
ZBTB7A C387F Added
ZBTB7A I391L Added
ZBTB7A R399L Added
ZBTB7A R402H Added
ZBTB7A T403N Added
ZBTB7A H404R Added
ZBTB7A G406V Added
ZBTB7A P409S Added
ZBTB7A C412Y Added
ZBTB7A K424N Added
ZBTB7A K424T Added
ZBTB7A R430W Added
ZBTB7A T461M Added
ZBTB7A L463M Added
ZBTB7A Y466D Added
ZBTB7A A522T Added
ZBTB7A E541K Added
ZBTB7A G562D Added
ZBTB7A D576V Added
ZBTB7A Gene Type Updated
```

### Evidence

```
ALK Oncogenic Mutations, Non-Small Cell Lung Cancer, Lorlatinib 1 Deleted
ALK Fusions, Non-Small Cell Lung Cancer, Lorlatinib 1 Added
BRCA1 Oncogenic Mutations, Prostate Cancer, Prostate Cancer, NOS, Rucaparib  Updated
BRCA2 Oncogenic Mutations, Prostate Cancer, Prostate Cancer, NOS, Rucaparib  Updated
MET 981_1028splice, 963_1010splice [Exon 14 splice mutations], X963_splice, X1006_splice, X1007_splice, X1008_splice, X1009_splice, X1010_splice Name Changed
	 New: 981_1028splice, 963_1010splice [Exon 14 splice mutations], X963_splice, X1006_splice, X1007_splice, X1008_splice, X1009_splice, X1010_splice
	 Old: 981_1028splice, 963_1010splice [Exon 14 splice mutations], X963_splice, X1006_splice, X1007_splice, X1008_splice, X1009_splice, X1010_splice, 963_1010del [Exon 14 in-frame deletions], Exon 14 Deletion
MET 963_1010del [Exon 14 in-frame deletions], Exon 14 Deletion Added
Other Biomarkers MSI-H [Microsatellite Instability-High], Endometrial Cancer, Tumor Type Summary Updated
Other Biomarkers MSI-H [Microsatellite Instability-High], Endometrial Cancer, Dostarlimab + Carboplatin + Paclitaxel 1 Added
RET Oncogenic Mutations, Medullary Thyroid Cancer, Tumor Type Summary Updated
RET Oncogenic Mutations, Medullary Thyroid Cancer, Pralsetinib 3A Added
RET Oncogenic Mutations, Medullary Thyroid Cancer, Pralsetinib 1 Deleted
RET Oncogenic Mutations, Other Tumor Types, Tumor Type Summary Updated
```
